Renaissance Technologies - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,047
-61.6%
178,500
-15.2%
0.00%
-62.5%
Q2 2023$5,328
-99.9%
210,517
-55.5%
0.01%
+14.3%
Q1 2020$6,996,000
-36.4%
472,700
-30.2%
0.01%
-12.5%
Q4 2019$10,995,000
-3.5%
677,473
-22.7%
0.01%
-20.0%
Q3 2019$11,393,000
-34.0%
876,373
-34.2%
0.01%
-33.3%
Q2 2019$17,263,000
+21.4%
1,330,973
+47.5%
0.02%
+15.4%
Q1 2019$14,217,000
+23.5%
902,073
+57.7%
0.01%0.0%
Q4 2018$11,512,000
+162.5%
571,873
+224.1%
0.01%
+160.0%
Q3 2018$4,385,000
-60.4%
176,454
-54.2%
0.01%
-16.7%
Q2 2018$11,073,000
+139.8%
385,100
+156.9%
0.01%
+20.0%
Q1 2018$4,617,000
+46.9%
149,900
+70.4%
0.01%
+66.7%
Q4 2017$3,144,000
+43.0%
87,956
+10.2%
0.00%0.0%
Q3 2017$2,198,000
-24.6%
79,792
-27.7%
0.00%
-25.0%
Q2 2017$2,914,000
-60.5%
110,373
-48.9%
0.00%
-75.0%
Q4 2015$7,375,000
+183.2%
215,900
+146.7%
0.02%
+166.7%
Q3 2015$2,604,000
-36.6%
87,500
-31.9%
0.01%
-33.3%
Q2 2015$4,109,000
+203.0%
128,500
+96.5%
0.01%
+200.0%
Q1 2015$1,356,00065,4090.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders